Glimivance MP 1mg/500mg/15mg Tablet
Marketer
OAK Vance Life Sciences Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimivance MP 1mg/500mg/15mg Tablet
Glycemic Control Tablets (GCT) – 1mg/500mg/15mg – combine medications to manage blood glucose. Used in conjunction with diet and exercise, GCT improves glycemic control in adult type 2 diabetics by enhancing insulin effectiveness and reducing blood sugar. Dosage and frequency should strictly adhere to physician instructions. Administer with food to minimize gastric distress. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosage risks hypoglycemia. Concurrent use with other antidiabetic agents, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is vital. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions, pregnancy, or breastfeeding necessitate physician consultation before initiating GCT therapy. Baseline kidney function assessment is mandatory. Limit alcohol consumption to mitigate potential side effects.
Uses of Glimivance MP 1mg/500mg/15mg Tablet
Managing Type 2 diabetes
Major Benefits of Glimivance MP 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimivance MP 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimivance MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimivance MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimivance MP 1mg/500mg/15mg tablets with food.
How Glimivance MP 1mg/500mg/15mg Tablet works:
Glimivance MP 1mg/500mg/15mg tablets contain a triple combination of glimepiride, metformin, and pioglitazone to manage blood sugar levels. These agents employ distinct mechanisms of action, offering superior glycemic control when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimivance MP 1mg/500mg/15mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Glimivance MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Glimivance MP 1mg/500mg/15mg Tablets. Preliminary data from human studies indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimivance MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimivance MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Glimivance MP 1mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimivance MP 1mg/500mg/15mg Tablet :
Should you forget a Glimivance MP 1mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimivance MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently